Pa. awards $6M to fight overdose deaths in underrepresented communities | Tuesday Morning Coffee
'Trends in drug overdose deaths show widening disparities,' a top official said.
County-by-county data on Pa.’s opioid deaths during pandemic defied stereotypes | Opinion
By Brian King, Andrea Rishworth, Louisa M. Holmes, and Ruchi Patel The Research Brief is a short take about interesting academic work. The big idea The COVID-19 pandemic intensified the opioid epidemic, according to our new research, which finds that opioid overdoses increased in Pennsylvania in 2020 compared with 2018 and 2019. Yet general trends […]
As opioids overdose deaths keep rising, report urges lawmakers to develop new approaches
Drug overdose rates in the U.S. have risen fivefold in the past two decades, according to the Centers for Disease Control and Prevention.
In rural America, the deadly costs of opioids outweigh the dollars tagged to address them
'Most folks know these individuals or know somebody who knows them,' Pamlico County Manager Tim Buck said.
No more empty seats at our holiday tables | Opinion
Overdoses took over 108,000 lives this year. Congress can save lives if it acts quickly.
Report: Stigma against people living with addiction entrenched in Pa. | Tuesday Morning Coffee
Hard hit by the opioid epidemic, Pa. residents take a dim view of people struggling with addiction, a new poll has found.
Senate Democratic panel takes up improving Pa. treatment centers amid rising overdose deaths
Though the Wolf administration and Republican-controlled Legislature have supported bills to make treatment more accessible and regulate the distribution and disposal of medications, overdose deaths have continued to increase, with a three-year high in 2020.
How the pandemic spread fentanyl across the U.S, causing overdose deaths to spike | Analysis
Fentanyl and fentanyl analogs were responsible for almost two-thirds of the overdose deaths recorded in the 12 months ending in April 2021.
Amid nationwide injectable Naloxone shortage, Pa. entities rely on Narcan supply
Naloxone, an injectable, intramuscular drug approved by the Food and Drug Administration for the rapid reversal of opioid overdoses, has been in scant supply since Pfizer, the drug’s maker, ran into manufacturing issues in 2020, causing the price of the Naloxone to soar even as demand for the drug increased during pandemic-fueled shutdowns, The Guardian reported earlier this month.
On Overdose Awareness Day, families, advocates call for Pa. to ‘recommit’ to fighting opioid epidemic
Joined by the Pennsylvania chapter of Team Sharing, a national nonprofit composed of parents who have lost children to substance use disorder, Smith called on the state government to “recommit” to managing the opioid epidemic.
Pa.’s emergency declaration is over. The opioid epidemic isn’t. We have more work to do | Opinion
We call on our leaders to work with those in the treatment space to create more prevention initiatives and ensure that we end this epidemic.
Spike in opioid overdose deaths during pandemic reinforces need for a holistic approach to public health issues | Opinion
The start of one new public health crisis didn't mean the end of another.